The 20 Best X-Linked Retinitis Pigmentosa (XLRP) Doctors Near Me in New York, NY

Richard Rosen is an Ophthalmologist practicing medicine in New York, New York. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Susan Fromer is an Ophthalmologist practicing medicine in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Golnaz Moazami is an Ophthalmologist practicing medicine in New York, New York. Dr. Moazami is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy. Dr. Moazami is board certified in American Board Of Ophthalmology.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy. Dr. Ritterband is board certified in American Board Of Ophthalmology.

John Seedor is an Ophthalmologist practicing medicine in New York, New York. Dr. Seedor is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Fuchs Dystrophy, Interstitial Keratitis, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy. Dr. Seedor is board certified in American Board Of Ophthalmology.

David Rubaltelli is an Ophthalmologist practicing medicine in Brooklyn, New York. Dr. Rubaltelli is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Kallikrein Hypertension, Congenital Toxoplasmosis, and Late-Onset Retinal Degeneration.

Louis Angioletti is an Ophthalmologist practicing medicine in New York, New York. Dr. Angioletti is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion. Dr. Angioletti is board certified in American Board Of Ophthalmology.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, Stargardt Macular Degeneration, and Usher Syndrome. Dr. Tsang is board certified in Ophthalmology. Dr. Tsang is currently accepting new patients.

Ian Chan is an Ophthalmologist practicing medicine in New York, New York. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Retinal Artery Occlusion, Neuroretinitis, and Late-Onset Retinal Degeneration.

Yasha Modi is an Ophthalmologist practicing medicine in Brooklyn, New York. Dr. Modi is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

John Khadem is an Ophthalmologist practicing medicine in New York, New York. Dr. Khadem is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Gennady Landa is an Ophthalmologist practicing medicine in New York, New York. Dr. Landa is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Richard Koplin is an Ophthalmologist practicing medicine in New York, New York. Dr. Koplin is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Vitreoretinochoroidopathy, Wagner Syndrome, Norrie Disease, Cataract, and Cataract Removal.

Anthony Curreri is an Ophthalmologist practicing medicine in New York, New York. Dr. Curreri is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Ocular Hypertension (OHT), Conjunctivitis (Pink Eye), Glaucoma, and Pinguecula.

James Klancnik is an Ophthalmologist practicing medicine in New York, New York. Dr. Klancnik is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion. Dr. Klancnik is board certified in American Board Of Ophthalmology, Diplomate and United States Medical Licensing Exam; Parts I, II, & III.

Richard Spaide is an Ophthalmologist practicing medicine in New York, New York. Dr. Spaide is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

"Dr. Rosenthal focuses particularly on the management of complex anterior segment surgery surgery on the front parts of the eye, such as the cornea and lens, usually using a laser. Dr. Rosenthal is frequently able to offer solutions to serious eye problems that cannot be treated elsewhere by conventional means.Laser vision correction LASIK and other proceduresTreatment of eye diseases especially cataracts, glaucoma, and corneal diseasesFull optical services glasses and contact lenses, both traditional and designer, with an emphasis on state-of-the-art lens technologies to allow the greatest comfort and depth of vision, at a reasonable priceAesthetic services eyelid surgery, brow lifts, BOTOX Cosmetic, and several dermal fillersA comprehensive ophthalmic testing facility to allow Dr. Rosenthal to make detailed and accurate diagnoses, thus providing him with the tools to treat eye diseases at an unmatched level of sophistication and precisionFirsts: Pioneering Work Making Eye Surgery Safer with Better Visual OutcomesDr. Rosenthal has been a leader in the development of minimally invasive cataract surgery. Preferring to avoid the use of needle injections behind the eyes for anesthesia, he developed and patented a non-invasive technique for placing very effective liquid anesthetics on the surface of the eye.Dr. Rosenthal holds an academic appointment (Associate Professor of Ophthalmology) at the prestigious John A. Moran Eye Center at the University of Utah School of Medicine, one of the leading academic, research, and patient care institutes in the world. He has developed new and innovative eye surgery technologies, and he has invented new instruments and techniques for eye surgery.Professional Leadership PositionsPresident, New York Intraocular Lens Implant SocietyPresident, New York Keratorefractive SocietyMember, International Intraocular Implant Club (a worldwide organization formed by one of the great pioneers of contemporary eye surgery, Sir Harold Ridley, who invented the intraocular lens -- Dr. Rosenthal is one of only three surgeons in the New York metropolitan area, and one of only 200 in the entire world to have been so honored)Board of Directors, Secretary, Windsor National AssociatesBoard of Directors, American College of Eye SurgeonsEditorial Board, Review of OphthalmologyEditorial Advisory Board, Ocular Surgery NewsPast President, Ophthalmic Anesthesia SocietyOther Professional Memberships and AwardsThe International Society of Refractive SurgeryThe American Academy of Ophthalmology - Honor Achievement AwardThe European Society of Cataract and Refractive SurgeonsAmerican College of Eye SurgeonsU.S. delegate to the European Society of Cataract and Refractive Surgeons.Voted one of the ""Best Doctors of Long Island""Featured in ""Strathmore's Who's Who""Featured in Who's Who of American InventorsNew York Magazine's ""Best Doctor in New York""". Dr. Rosenthal is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Dry Eye Syndrome, Cataract, Blepharitis, Eyelid Bump, and Cataract Removal.

Philip Ferrone is an Ophthalmologist practicing medicine in Elmhurst, New York. Dr. Ferrone is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy. Dr. Ferrone is board certified in American Board Of Ophthalmology.

Angie Wen is an Ophthalmologist practicing medicine in New York, New York. Dr. Wen is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Keratoconus, Blepharitis, Glaucoma, and Cataract.

Bingjing Roberts is an Ophthalmologist practicing medicine in New York, New York. Dr. Roberts is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Dry Eye Syndrome, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).